NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

ASX:NSB Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.11	7.27	4.95	4.91	7.22	14.16
Cash & Short-Term Investments	6.36	7.27	4.95	4.91	7.22	14.16
Cash Growth	-12.50%	46.66%	0.86%	-31.93%	-49.05%	330.88%
Accounts Receivable	0.12	0.1	0.05	0.04	0.12	0.05
Receivables	0.12	0.1	0.05	0.04	0.12	0.05
Prepaid Expenses	0.1	0.03	0.04	0.05	0.06	0.22
Total Current Assets	6.57	7.4	5.04	5.01	7.4	14.43
Property, Plant & Equipment	0	0	0.01	0.01	0.02	0.03
Other Intangible Assets	10.09	9.57	0.39	0.27	0.32	0.37
Total Assets	16.66	16.96	5.44	5.29	7.74	14.83

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	0.19	0.15	0.08	0.59	2.17	0.18
Accrued Expenses	0.02	-	0	0.01	0.05	0.05
Total Current Liabilities	0.21	0.15	0.09	0.6	2.22	0.22
Total Liabilities	0.21	0.15	0.09	0.6	2.22	0.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	34.26	34.26	25.52	25.27	25.27	25.27
Retained Earnings	-24.98	-23.28	-22.04	-22.99	-22.6	-12.18
Comprehensive Income & Other	7.18	5.84	1.87	2.41	2.84	1.5
Shareholders' Equity	16.45	16.81	5.35	4.69	5.52	14.6
Total Liabilities & Equity	16.66	16.96	5.44	5.29	7.74	14.83

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Cash (Debt)	6.36	7.27	4.95	4.91	7.22	14.16
Net Cash Growth	-12.50%	46.66%	0.86%	-31.93%	-49.05%	330.88%
Net Cash Per Share	0.03	0.05	0.03	0.03	0.05	0.10
Filing Date Shares Outstanding	332.58	332.58	144.6	143.47	143.47	143.47
Total Common Shares Outstanding	332.58	332.58	144.6	143.47	143.47	143.47
Working Capital	6.37	7.25	4.96	4.41	5.18	14.2
Book Value Per Share	0.05	0.05	0.04	0.03	0.04	0.10
Tangible Book Value	6.37	7.25	4.96	4.42	5.2	14.23
Tangible Book Value Per Share	0.02	0.02	0.03	0.03	0.04	0.10

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 5, 2026

Data Sources Report a data error